Literature DB >> 9579707

Differences in plasma concentrations of the D- and L-threo methylphenidate enantiomers in responding and non-responding children with attention-deficit hyperactivity disorder.

L M Jonkman1, M N Verbaten, D de Boer, R A Maes, J K Buitelaar, C Kemner, H van Engeland, H S Koelega.   

Abstract

Children with attention-deficit hyperactivity disorder who are categorized as responders or non-responders to methylphenidate (MPH) on the basis of their electrophysiological P3 response in a selective attention task differ in metabolic patterns of the D- and L-threo MPH enantiomers. Non-responders showed significantly higher plasma concentrations of both D- and L-threo MPH enantiomers.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9579707     DOI: 10.1016/s0165-1781(97)00138-8

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  4 in total

Review 1.  Evolution of stimulants to treat ADHD: transdermal methylphenidate.

Authors:  Kennerly S Patrick; Arthur B Straughn; Jeb S Perkins; Mario A González
Journal:  Hum Psychopharmacol       Date:  2009-01       Impact factor: 1.672

2.  Influence of ethanol and gender on methylphenidate pharmacokinetics and pharmacodynamics.

Authors:  K S Patrick; A B Straughn; R R Minhinnett; S D Yeatts; A E Herrin; C L DeVane; R Malcolm; G C Janis; J S Markowitz
Journal:  Clin Pharmacol Ther       Date:  2007-03       Impact factor: 6.875

Review 3.  Pharmacokinetic and pharmacodynamic drug interactions in the treatment of attention-deficit hyperactivity disorder.

Authors:  J S Markowitz; K S Patrick
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

4.  Enantiospecific gas chromatographic-mass spectrometric analysis of urinary methylphenidate: implications for phenotyping.

Authors:  Natalie L LeVasseur; Hao-Jie Zhu; John S Markowitz; C Lindsay DeVane; Kennerly S Patrick
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2007-12-04       Impact factor: 3.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.